QJM Advance Access published online on October 21, 2009
QJM, doi:10.1093/qjmed/hcp145
The long road of biopharmaceutical drug development: from inception to marketing
From the Rheumatology Research Unit, Addenbrookes Hospital, Hills Road, Cambridge, CB2 2QQ, UK
Address correspondence to M.K. Mundae, Rheumatology Research Unit, Addenbrookes Hospital, Hills Road, Cambridge, CB2 2QQ, UK. email: maninderkmundae{at}googlemail.com, maninder.mundae{at}googlemail.com
| Abstract |
|---|
The development of therapeutics is costly, time-consuming and has high attrition rates. Biopharmaceutical medications differ from traditional agents in their discovery, design, structure and formulation. Prior to marketing a drug must show efficacy and acceptable toxicity in both preclinical and clinical trials. Regulatory bodies have a pivotal role in the licensing, naming and marketing of an agent.